THE FIRST EXPERIENCE WITH TISSUCOL AT MOSCOW CITY CANCER HOSPITAL SIXTY-TWO
https://doi.org/10.17650/2222-1468-2013-0-4-20-22
Abstract
The paper describes the first experience with the fibrin sealant Tissucol at Moscow City Cancer Hospital Sixty-Two. The authors used this agent in different clinical situations. However, Tissucol showed the highest efficacy in arresting long-term severe lymphorrhea. The described clinical case clearly demonstrates the abilities of this agent and allows it to be recommended for use in other areas of oncology.
About the Authors
E. N. Novozhilova
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
A. P. Fedotov
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
M. V. Novozhilov
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
M. V. Paskova
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
References
1. Инструкция по применению Тиссукола.
2. Red H., Cooper M. et al. The influence of lonic additives on fibrin structure and on the morfology and grouth of human fibroblasts / comparison of two fibrin glues. Med Welt 1995;85(22):769–77.
3. Gouillat C., Tete B., Frering V. et al. Evaluation of the effectiveness of two fibrin glue for patients undergoing resternotomy or reoperation after cardiac operations. Multicentral Study. J Thorac Cardiovasc Surg 1999;87;234–53.
4. Data of file. Baxter Health Corporation 2011, p. 37.
Review
For citations:
Novozhilova E.N., Fedotov A.P., Novozhilov M.V., Paskova M.V. THE FIRST EXPERIENCE WITH TISSUCOL AT MOSCOW CITY CANCER HOSPITAL SIXTY-TWO. Head and Neck Tumors (HNT). 2013;(4):20-22. (In Russ.) https://doi.org/10.17650/2222-1468-2013-0-4-20-22
Views:
522
Email this article 